Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.
安徽智飞龙科马生物制药有限公司
0
vacancies
vacancies
Pharmaceuticals
About
Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.
Company Size
1001 - 10,000
Anhui Zhifei Longcom Biopharmaceutical Co., Ltd.
Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. was acquired by Zhifei Biological in 2008,is a high-tech enterprise which integrates the R&D, production and sales of biological products. Our company now has 3 Self-developed Products including Recombinant COVID-19 Vaccine(CHO Cell) ZIFIVAX®,Mycobacterium for Injection Vaccae®,Recombinant Mycobacterium tuberculosis fusion protein (EC) C-TST, and 2 upcoming products:Rabies（MRC-5 cell）and Flu- Quadrivalent.